Reem Alsalem, the UN's Special Rapporteur on violence against women and girls, has accused the World Health Organization (WHO) of taking a "one-sided" pro-medicalizing position on the issue of transgender healthcare. Referring to the WHO's recently established 21-person committee on trans health guidelines, Alsalem said the panel contained "significant unmanaged conflicts of interest."
The WHO, which is a UN agency, is inviting the 21-member panel to its headquarters next month to hold a discussion focused on transgender treatments as well as the "legal recognition of self-determined gender identity."
The WHO has no care for the safety of biological women or people caught up in the gender dysphoria diagnosis frenzy. None of the 21 so-called experts on this panel have any intellectual diversity — in fact, their intellectual conflicts of interest are likely also financial conflicts of interest, as academic and activist work is typically tied to investment or salaries. Beyond that, these panelists have been documented calling for medical transitions of children and have called nonmedical solutions "conversion therapy." All they care about is pushing a political agenda, not helping people.
The WHO is a leading international health body, so accusations of bias are themselves uninformed and politically motivated. This panel has not only been vetted but has been carefully curated to include experts from both the medical and nonmedical world. The goal of this coalition is to discuss how to provide global healthcare to marginalized communities in a safe and scientifically informed manner. Evidence of this is shown through the WHO's honest and transparent publication of the panelists and their résumés.